Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia

Sophia Vinogradov, Melissa Fisher, Heather Warm, Christine Holland, Margaret A. Kirshner, and Bruce G. Pollock

Am J Psychiatry 2009; 166:1055-1062

GRATIS 3! - Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

Douglas E. Faries, Haya Ascher-Svanum, Allen W. Nyhuis and Bruce J. Kinon

BMC Psychiatry 2009, 9:54

 

3 - Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment

I. Amado, M.C. Bourdel, C. Daban, M.F. Poirier, H. Loo, P. Bouhours and M.O. Krebs

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 7, 1 October 2009, Pages 1107-1112  

 

3 - Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

Samtani, Mahesh N.; Vermeulen, An; Stuyckens, Kim

Clinical Pharmacokinetics: 1 September 2009 - Volume 48 - Issue 9 - pp 585-600

 

5 - Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol

Steven G. Potkin, Peter J. Weiden, Antony D. Loebel, Lewis E. Warrington, Eric J. Watsky and Cynthia O. Siu

The International Journal of Neuropsychopharmacology (2009), 12:1233-1248

 

5 - Treatment of Clozapine-Induced Hypersalivation With Ipratropium Bromide: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Sanjeev Sockalingam, Chekkera Shammi, and Gary Remington

J Clin Psychiatry 2009;70(8):1114–1119

 

3! - Paternal age as a risk factor for schizophrenia: How important is it?

E. Fuller Torrey, Stephen Buka, Tyrone D. Cannon, Jill M. Goldstein, Larry J. Seidman, Tianli Liu, Trevor Hadley, Isabelle M. Rosso, Carrie Bearden and Robert H. Yolken

Schizophrenia Research. Volume 114, Issues 1-3, October 2009, Pages 1-5

 

3 - Schizophrenia and breast cancer incidence: A systematic review of clinical studies

Chris J. Bushe, Andrew J. Bradley, Hiram J. Wildgust and Richard E. Hodgson

Schizophrenia Research. Volume 114, Issues 1-3, October 2009, Pages 6-16

 

3! - Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis

S.M. Cotton, M. Lambert, B.G. Schimmelmann, D.L. Foley, K.I. Morley, P.D. McGorry and P. Conus

Schizophrenia Research. Volume 114, Issues 1-3, October 2009, Pages 17-24

 

3! - Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis

Kia Faridi, Nicole Pawliuk, Suzanne King, Ridha Joober and Ashok K. Malla

Schizophrenia Research. Volume 114, Issues 1-3, October 2009, Pages 57-63

 

5 - FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia

Monte S. Buchsbaum, Mehmet Haznedar, Randall E. Newmark, King-Wai Chu, Nicola Dusi, Jonathan J. Entis, Kim E. Goldstein, Chelain R. Goodman, Adarsh Gupta, Erin Hazlett, James Iannuzzi, Yuliya Torosjan, Jane Zhang and Adam Wolkin

Schizophrenia Research. Volume 114, Issues 1-3, October 2009, Pages 161-171

 

3 - Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory–verbal hallucinations in schizophrenia: A randomized controlled trial

Ans Vercammen, Henderikus Knegtering, Richard Bruggeman, Hanneke. M. Westenbroek, Jack A. Jenner, Cees J. Slooff, Lex Wunderink and André Aleman

Schizophrenia Research. Volume 114, Issues 1-3, October 2009, Pages 172-179

 

5 - Second-generation antipsychotics for schizophrenia: can we resolve the conflict?

S. Leucht, W. Kissling and J. M. Davis

Psychological Medicine (2009), 39:1591-1602 (2009), 39:1591-1602

 

3! - Economic impact of early intervention in people at high risk of psychosis

L. R. Valmaggia, P. McCrone, M. Knapp, J. B. Woolley, M. R. Broome, P. Tabraham, L. C. Johns, C. Prescott, E. Bramon, J. Lappin, P. Power and P. K. McGuire

Psychological Medicine (2009), 39:1617-1626 (2009), 39:1617-1626

 

3 - Does Level of Care, Sex, Age, or Choice of Drug Influence Adherence to Treatment With Antipsychotics?

Castberg, Ingrid; Westin, Andreas Austgulen; Spigset, Olav

Journal of Clinical Psychopharmacology: October 2009 - Volume 29 - Issue 5 - pp 415-420

 

3 - Effects of Aripiprazole on Insight and Subjective Experience in Individuals With an At-Risk Mental State

Kobayashi, Hiroyuki; Morita, Keiko; Takeshi, Kiyoaki; Koshikawa, Hiroki; Yamazawa, Ryoko; Kashima, Haruo; Mizuno, Masafumi

Journal of Clinical Psychopharmacology: October 2009 - Volume 29 - Issue 5 - pp 421-425

 

3 - Antipsychotic Drugs for First-Episode Schizophrenia: A Comparative Review

Salimi, Kayvon; Jarskog, L. Fredrik; Lieberman, Jeffrey A

CNS Drugs: 1 October 2009 - Volume 23 - Issue 10 - pp 837-855

 

3 - Iloperidone: In Schizophrenia

Scott, Lesley J

CNS Drugs: 1 October 2009 - Volume 23 - Issue 10 - pp 867-880

 

GRATIS 3! - Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

Kwang H Choi, Brandon W Higgs, Serge Weis, Jonathan Song, Ida C Llenos, Jeannette R Dulay, Robert H Yolken and Maree J Webster

BMC Psychiatry 2009, 9:57

 

3 - Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study

Zhanlian Feng, John P. Hirdes, Trevor F. Smith, Harriet Finne-Soveri, Iris Chi, Jean-Noel Du Pasquier, Ruedi Gilgen, Naoki Ikegami, Vincent Mor

International Journal of Geriatric Psychiatry. Volume 24 Issue 10, Pages 1110 - 1118

 

GRATIS 3 - Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder

Delia Bishara, David Taylor

Neuropsychiatric Disease and Treatment. Published Date September 2009

 

3 - Cannabis and psychosis/schizophrenia: human studies

Deepak Cyril D’Souza, Richard Andrew Sewell and Mohini Ranganathan

European Archives of Psychiatry and Clinical Neuroscience. Volume 259, Number 7 / October, 2009: 413-431

 

3 - Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia

Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Seung-Hyun Lee, Yo-Han Lee, Su-Jin Yang, Jin-Sang Yoon

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 7, Pages 565 - 573

 

3 - Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder

Alessandro Rossi, Anna Bagalà, Vincenzo Del Curatolo, Francesco Scapati, Micaela Maria Bernareggi, Maria Grazia Giustra, on behalf of the Risperidone Long-Acting Trial Investigators (R-LAI)

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 7, Pages 574 - 583

 

2! - Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children

Anand Mattai, Lawrence Fung, Jennifer Bakalar, Gerald Overman, Julia Tossell, Rachel Miller, Judith Rapoport, Nitin Gogtay

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 7, Pages 584 - 589

 

3 - A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia

Michelle Y. Deng, Gráinne M. McAlonan, Charlton Cheung, Cindy P. Y. Chiu, Chi W. Law, Vinci Cheung, Pak C. Sham, Eric Y. H. Chen and Siew E. Chua

Psychopharmacology. Volume 206, Number 3 / October, 2009: 437-446

 

3 - Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients

Bernard Lerer

Psychopharmacology. Volume 206, Number 3 / October, 2009: 491-499

 

3 - Short-term treatment with olanzapine does not modulate gut hormone secretion; olanzapine disintegrating vs standard tablets
Vidarsdottir S, Roelfsema F, Streefland T, Holst J, Rehfeld J, Pijl H

Eur J Endocrinol. 2009 Sep 24. [Epub ahead of print]

 

3! - Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database

Hélène Peyrière, Clarisse Roux, Claire Ferard, Nathalie Deleau, Carmen Kreft-Jais, D. Hillaire-Buys, Jean-Philippe Boulenger, Jean-Pierre Blayac, The French Network of the Pharmacovigilance Centers

Pharmacoepidemiology and Drug Safety. Volume 18 Issue 10, Pages 948 - 955

 

 

.

Regresar a RESÚMENES SEPTIEMBRE 2009